lung-cancer

Documents about lung-cancer

• Neutrophil-to-lymphocyte ratio affects the impact of proton pump inhibitors on efficacy of immune checkpoint inhibitors in patients with non‑small-cell lung cancer#194772OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Image 4_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.tiff#442373Figshare
• Image 3_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.tiff#442374Figshare
• Image 5_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.tif#442375Figshare
• Image 6_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.tif#442376Figshare
• Table 1_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.docx#442377Figshare
• Image 1_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.tif#442378Figshare
• Image 2_A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study.tif#442379Figshare
• Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing#125827ClinicalTrials.gov
• First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy#184846ClinicalTrials.gov
• Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung Cancer#272330ClinicalTrials.gov
• Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Patients With Brain Metastases#283217ClinicalTrials.gov
• A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors#405118ClinicalTrials.gov
• Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapy#126926HAL (France)
• Integrating Lung Tissue-based Transcriptome-Wide Association Study with Single-cell RNA-sequencing Uncovers Susceptibility Genes and Cell Types Underlying Lung Cancer Risk#130557Unpaywall
• A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies#353286ClinicalTrials.gov
• Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer#287530ClinicalTrials.gov
• Cortisol-resistant CAR-NK cells overcome steroid-induced immunosuppression in lung cancer.#983NCBI PubMed Central
• Cortisol-resistant CAR-NK cells overcome steroid-induced immunosuppression in lung cancer#5442Europe PMC
• Patient and Healthcare Provider Barriers in the LDCT Lung Cancer Screening Continuum.#9332NCBI PubMed Central
• Harnessing exhaled breath for lung cancer early detection, results from the ExPeL study#29728bioRxiv / medRxiv
• Dual-Modal Lung Cancer AI: Interpretable Radiology and Microscopy with Clinical Risk Integration#31316arXiv CS
• A Study to Evaluate D-1553 in Combination Therapy in Non-Small Cell Lung Cancer#125859ClinicalTrials.gov
• A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC#127585ClinicalTrials.gov
• The combined inhibitory effect of butaselen and decitabine against lung cancer cells.#165656NCBI PubMed Central
• The mutagenic forces shaping the genomes of lung cancer in never smokers#208777HAL (France)
• Advancing Lung Cancer Staging: Integrating IASLC Recommendations and Bioinformatics to Delineate Tumor Origins#218155HAL (France)
• County-Level Structural Racism Indices and Racial Disparities in Lung Cancer Care.#219151NCBI PubMed Central
• Will We Need a Novel Heuristic in Resectable Lung Cancer?: A Narrative Review.#232232NCBI PubMed Central
• Immunotherapy in Patient With Poor General Condition#256903ClinicalTrials.gov
• Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients#272335ClinicalTrials.gov
• ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC#303747ClinicalTrials.gov
• Circadian rhythms and lung cancer biology and immunotherapy: Emerging opportunities and challenges.#338425NCBI PubMed Central
• Risk prediction for lung cancer screening: a systematic review and meta-regression.#354858NCBI PubMed Central
• Intrathecal Double Checkpoint Inhibition#369820ClinicalTrials.gov
• Advances in porphyrin-based photosensitizers for photodynamic therapy of A549 lung cancer.#371554NCBI PubMed Central
• Phase II Clinical Trial of NIVO-IPI-TAXANE in Untreated Metastatic NSCLC#387162ClinicalTrials.gov
• Table 2_Development and validation of an interpretable machine learning model for venous thromboembolism risk prediction in patients with lung cancer: a real-world study.docx#347347Figshare
• Table 1_Development and validation of an interpretable machine learning model for venous thromboembolism risk prediction in patients with lung cancer: a real-world study.docx#347348Figshare
• Table 4_Development and validation of an interpretable machine learning model for venous thromboembolism risk prediction in patients with lung cancer: a real-world study.docx#347349Figshare
• Table 3_Development and validation of an interpretable machine learning model for venous thromboembolism risk prediction in patients with lung cancer: a real-world study.docx#347350Figshare
• Inhaled mRNA Immunotherapy for Patients With Advanced Lung Cancer or Pulmonary Metastatic Solid Tumors#311119ClinicalTrials.gov
• Global lung cancer burden, trends, and projections from 2010 to 2050: A population-level severity framework integrating DALYs-per-case and mortality-to-incidence ratio#396704PLOS
• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer#184860ClinicalTrials.gov
• Stochastic analysis of tumor microenvironment dynamics: Interplay between cytotoxic T-cells and cancer-associated fibroblasts#250325HAL (France)
• A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors#272344ClinicalTrials.gov
• Quality of life after the initial treatments of non-small cell lung cancer: a persistent predictor for patients' survival.#231451HAL Science
• Budget impact of implementing AI-enabled chest X-ray based incidental pulmonary nodule detection for early lung cancer diagnosis: models from Colombia, Costa Rica, Mexico, Thailand and Vietnam.#313080PubMed
• A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma#394772ClinicalTrials.gov
• Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC#148772ClinicalTrials.gov